Colorectal Cancer: A Global Challenge Colorectal cancer (CRC) is among the most common and deadly cancers worldwide. It accounts for 9.6% of all cancer cases and is the second leading cause of cancer-related death, responsible […]
Colorectal cancer: high incidence, stubborn mortality According to the 2022 GLOBOCAN survey, colorectal cancer (CRC) stands fourth worldwide for new cancer cases and third for cancer-related deaths. Despite multimodal treatments—including surgery, chemotherapy and targeted agents—outcomes […]
Colorectal cancer remains a growing challenge Colorectal cancer (CRC) is the world’s third‑most frequently diagnosed malignancy, adding roughly 1.9 million new cases every year—about one in ten of all cancers. Even more concerning is the sharp […]
For the past four decades, the 67 kDa laminin receptor (67LR) has been a central focus of cancer research, especially in the study of colorectal carcinoma. This receptor was hypothesized to consist of a complex […]
Colorectal cancer is the 3rd most common cancer worldwide. Immunotherapy has been shown to be therapeutically effective in patients with colorectal cancer who have significant levels of microsatellite instability (regions of repeated DNA that change […]
Irritable bowel syndrome (IBS) represents one of the most frequent functional gastrointestinal disorders. However, despite intensive research conducted in this field, IBS is still in search for a reliable biomarker. Up to the present time, […]
Colorectal cancer is one of the most prevalent and lethal disorders worldwide. There is an increseas in its incidence during the last two decades. Besides the environmental contributing factors, genetic variations are also responsible for […]
Copyright (c) 2021 Association of Basic Medical Sciences of FBIH